Summary by Moomoo AI
On January 3, 2025, Morgan Stanley Asia Limited (MSAP) conducted derivatives transactions of PA GOODDOCTOR (Ping An Healthcare Technology Company Limited) through Morgan Stanley Hong Kong Limited (MSHK). As a designated market maker recognized by the Hong Kong Exchange, MSHK sold 100,000 shares on behalf of MSAP for a total of 16,500 HKD, with a price of 0.1650 HKD per share; at the same time, it bought 152,000 shares for a total of 25,700 HKD, with a price ranging from 0.1650 to 0.1760 HKD per share.These transactions were conducted prior to a possible mandatory general offer period and are part of the activities of market makers or liquidity providers for existing derivatives or Exchange-traded Options. MSHK is classified as a type (5) connected person related to the offeror and conducted the transactions on its own account. Notably, both MSHK and MSAP are companies ultimately owned by Morgan Stanley.
